Cervical vertebra disease capsule and its manufacturing method
A technology for cervical spondylosis and capsules, which is applied in the field of oral medicine for the treatment of cervical spondylosis, and can solve problems such as loss of labor force, many postoperative sequelae, and heavy economic burden
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2005-01-05
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to an oral medicine for treating cervical spondylosis, in particular to a capsule for cervical spondylosis and a preparation method thereof. Background technique
[0002] Modern medicine believes that "cervical spondylosis" belongs to "bone degeneration", and modern medicine recognizes "a type of osteoarthritis in middle-aged and elderly people" as one of the concepts of "ten years of bone and joint". Its morbidity rate is high, 80% are over 50 years old, and 12.5% of them cause mobility impairment seriously. Abnormal bone metabolism as a whole is related to endocrine and immune functions. In severe cases, it affects cerebral blood vessels and causes lingering pain. Modern medical treatment plan: symptomatic treatment, traction, surgery, symptomatic pain relief. The long-term result is that there are many side effects and postoperative sequelae, and even loss of labor force, resulting in heavy economic burden. Soreness and we...
Examples
Embodiment 1
[0054] Example 1 (high metering)
[0055] The weight ratio is calculated as 1g per serving:
[0056] Pueraria 35g, Clematis 80g, Caulis Spatholobus 80g, Salvia miltiorrhiza 65g, notopterygium 40g, rehmannia glutinosa 60g, angelica 30g, antler gum 30g, chuanxiong 30sg, drynaria 65g.